Search events

This year’s conference program, taking place at the QT Hotel, Surfers Paradise, will feature leading international and national speakers, panel sessions, workshops and discussions exploring the importance of our theme 'Innovation to Adoption: Delivering Real Impact'. Don't miss your chance to learn from others, share your experiences and challenges, as well as participate in the opportunity to network and collaborate with your peers. BioCurate Director of Project Management Dr Cathy Drinkwater will be attending The program, more information and registration…

The upcoming Hit ID Symposium will be held on 27 October 2023 at the Woodward Conference Centre, in Melbourne, Australia. This event will consist of scientific sessions, interactive events and networking opportunities focussed on introducing delegates to the topic of hit identification within a small molecule drug discovery setting. This is the first small molecule drug discovery symposium showcasing the hit identification infrastructure available within Melbourne’s Parkville precinct, with a series of drug development success stories. The event provides a…

Melbourne Therapeutics (MTx) and Victorian Comprehensive Cancer Centre (VCCC) Alliance presents the third edition of the INNOVATION 2 TRANSLATION symposium – to be held Tuesday 5th December at the Woodward Conference Centre – University of Melbourne (10th Floor, Melbourne Law Building, 185 Pelham St, Carlton). A showcase of the current commercial & translational research occurring across the Melbourne Biomedical Precinct, highlighting remarkable stories focused on therapeutic discovery & development. This year's symposium will also host an internal pitch session with…

The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over 20,000 industry leaders from across the globe. Dr Christopher Chan (Executive Director, Research and Development), Dr Eric Hayes (Director of Partnerships) and Francis Kirby (Partnerships and Strategy Manager) will be attending the event More information and registration details can be found here.

The 5th Fragment-Based Drug Discovery Down Under Meeting (FBDD-DU5) will be held at UQ City Campus in Brisbane, Australia from 25 to 27 June 2024. The 2024 conference will bring together an expanding multidisciplinary group of biologists, biochemists, biophysicists, and chemists from academia and industry to hear about the latest techniques and progress in the dynamic and exciting field of fragment-based drug design. Dr Tifelle Reisinger (Associate Director, Medicinal Chemistry Discovery and Stakeholder Management) and Dr Julia Beveridge (Scientist, Small…

Calling all translational researchers! The BioCurate Proof of Concept team will be at the Clayton campus on Tuesday 16 July to present information on this year’s BioCurate Opportunity Assessment round and to hear brief project pitches from researchers that are considering applying to BioCurate for Proof of Concept funding. The BioCurate Proof of Concept scheme allows for funding of up to $500,000 for a defined set of experiments that will provide industry-standard validation of your discovery. Register the event by…

Find out how BioCurate can help you translate your research at our Information Session Join us to learn more about BioCurate's evaluation and selection process, the Proof-of-Concept Fund, and our new funding model, ahead of the next round of BioCurate Opportunity Assessment (BOA) applications. The information session will be followed by a panel, and then networking lunch (12pm onwards) at Melbourne Connect. Please let us know if you have any dietary requirements by emailing info@biocurate.com. Speakers: Location: The Studio (Ground…

The 7th Annual Bio Connections Australia will return to Melbourne in 29th July 2024 in the Crown Promenade Melbourne. Bio Connections Australia is an annual event for the biotech industry which provides a unique platform for networking, discussion and thought leadership. The conference focuses on translating medical research into commercialisation, drug discovery and development, early phase clinical trials and expediting Australia’s great science into commercialisation. Bringing together key industry stakeholders from across the ecosystem: biotech’s (both domestic and international), pharma,…